SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-752501
Filing Date
2016-10-31
Accepted
2016-10-31 08:00:47
Documents
34
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d263307d10q.htm 10-Q 158657
2 CERTIFICATION d263307dex311.htm EX-31.1 6135
3 CERTIFICATION d263307dex312.htm EX-31.2 6138
4 CERTIFICATION d263307dex321.htm EX-32.1 2895
5 CERTIFICATION d263307dex322.htm EX-32.2 2898
  Complete submission text file 0001193125-16-752501.txt   1078794

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20160930.xml EX-101.INS 96430
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20160930.xsd EX-101.SCH 19367
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20160930_cal.xml EX-101.CAL 20592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20160930_def.xml EX-101.DEF 51114
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20160930_lab.xml EX-101.LAB 152775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20160930_pre.xml EX-101.PRE 95628
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 161960069
SIC: 8731 Services-Commercial Physical & Biological Research